Gilead Sciences Inc to ramp up production of experimental COVID-19 treatment with international partners

In a statement Gilead Sciences Inc, the maker of the closely-watched experimental coronavirus drug remdesivir stated, it will continue to work with international partners to expand the production of its potential COVID-19 treatment. Gilead said, it expects to have more than one million remdesivir treatment courses manufactured by December, “with plans to be able to…

FBI’s Counterintelligence Division admits to slow response in China’s theft of U.S. intellectual property

During a testimony to the U.S. Senate, the FBI said it wished it had taken swifter action with regard to Chinese recruitment of U.S.-based researchers to transfer intellectual property from American laboratories. The admission by John Brown, assistant director of the Counterintelligence Division at the FBI, backed up a Senate subcommittee report which concluded that…